A Randomised Study Comparing Granulocyte-colony Stimulating Factor (G-CSF) with G-CSF Plus Thymostimulin in the Treatment of Haematological Toxicity in Patients with Advanced Breast Cancer after High Dose Mitoxantrone Therapy

By Sanchiz F.   Milla A.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 52-56

Elsevier

Access to resources Recommend Favorite

Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

By Shikata Hisaharu   Yakushijin Yoshihiro   Yamanouchi Jun   Azuma Taichi   Yasukawa Masaki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 178-185

Springer Publishing Company

Access to resources Recommend Favorite

Clinical efficacy of adjunctive G-CSF on solid tumor and lymphoma patients with established febrile neutropenia

By Chan Alexandre   Wong Qi   Ali Mohamed   Wong Mabel   Hsu Li  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 1105-1112

Springer Publishing Company

Access to resources Recommend Favorite

The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia

By Haim Nissim   Shulman Katerina   Goldberg Hadassah   Tsalic Medy  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 229-232

Humana Press, Inc

Access to resources Recommend Favorite

G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis

By Grigull Lorenz   Pulver Nicole   Goudeva Lilia   Sykora Karl-Walter   Linderkamp Christin   Beilken Andreas   Seidemann Kathrin   Schmid Hansjörg   Welte Karl   Heuft Hans-Gert  

Supportive Care in Cancer, Vol. 14, Iss. 9, 2006-09 ,pp. : 910-916

Springer Publishing Company

Access to resources Recommend Favorite